Artia Global Partners’s AstraZeneca AZN Stock Holding History

Artia Global Partners’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$18.8M	Hold	95,376	–	–	3.77%	7
2025 Q4	$17.5M	Hold	95,376	–	–	2.48%	12
2025 Q3	$14.6M	Hold	95,376	–	–	2.32%	16
2025 Q2	$13.3M	Hold	95,376	–	–	3.21%	9
2025 Q1	$14M	Hold	95,376	–	–	3.55%	10
2024 Q4	$12.5M	Hold	95,376	–	–	4.47%	10
2024 Q3	$14.9M	Hold	95,376	–	–	4.05%	5
2024 Q2	$14.9M	Hold	95,376	–	–	2.88%	7
2024 Q1	$12.9M	Hold	95,376	–	–	2.6%	9
2023 Q4	$12.8M	Hold	95,376	–	–	3.74%	9
2023 Q3	$12.9M	Hold	95,376	–	–	5.37%	6
2023 Q2	$13.7M	Buy	95,376 +44,222	+86%	+$6.51M	4.71%	5
2023 Q1	$7.1M	Buy	51,154 +12,274	+32%	+$1.65M	2.62%	14
2022 Q4	$5.27M	Buy	+38,880	New	+$4.88M	2.01%	13

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Artia Global Partners's AZN Position: Q1 2026 in Review

Artia Global Partners held its AstraZeneca (AZN) position steady in Q1 2026 at 95,376 shares worth $18.8M. The position accounts for 3.77% of the portfolio, ranked #7.

Artia Global Partners first reported a position in AZN in Q4 2022 and has held it in 14 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Artia Global Partners held 95,376 shares of AstraZeneca worth $18.8M as of Q1 2026.
Artia Global Partners left its AstraZeneca share count unchanged in Q1 2026.
AstraZeneca made up 3.77% of Artia Global Partners's portfolio in Q1 2026, its #7 holding.
Artia Global Partners first reported a position in AstraZeneca in Q4 2022 and has held it in 14 quarters since.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Artia Global Partners's 13F filing for Q1 2026, filed 15 May 2026.